retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Retatrutide: The "Triple G" Peptide That Could Rival Bariatric Surgery (And Why You Shouldn't Wait) Who Makes Retatrutide? Company Behind
Description
10.1042/CS20130708 50 SuhrsH
Expert Commentary The rise of GLP-1 receptor agonists like semaglutide and tirzepatide reflects a major shift in how we approach both type 2 diabetes and obesity
Tuttle KR
Total protein was measured using the bicinchoninic acid protein assay (P0010, BCA, Beyotime, Shanghai, China)
Eur J Cell Biol (2017) 96:24053
